Valion Bio, Inc. (VBIO) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.00M | -22.3% |
| 2024 | -$5.72M | +32.7% |
| 2023 | -$8.51M | +4.6% |
| 2022 | -$8.92M | -58.9% |
| 2021 | -$5.61M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.00M | -22.3% |
| 2024 | -$5.72M | +32.7% |
| 2023 | -$8.51M | +4.6% |
| 2022 | -$8.92M | -58.9% |
| 2021 | -$5.61M | — |